Antiviral activities of ginseng and its potential and putative benefits against monkeypox virus: A mini review

Journal of Ginseng Research

Available online 1 April 2023

Journal of Ginseng ResearchAuthor links open overlay panel, , , , , , , Abstract

Due to the Covid-19 pandemic more than 6 million people have died, and it has bought unprecedented challenges to our lives. The recent outbreak of monkeypox virus (MPXV) has brought out new tensions among the scientific community. Currently, there is no specific treatment protocol for MPXV. Several antivirals, vaccinia immune globulin (VIG) and smallpox vaccines have been used to treat MPXV. Ginseng, one of the more famous among traditional medicines, has been used for infectious disease for thousands of years. It has shown promising antiviral effects. Ginseng could be used as a potential adaptogenic agent to help prevent infection by MPXV along with other drugs and vaccines. In this mini review, we explore the possible use of ginseng in MPXV prevention based on its antiviral activity.

Keywords

Korean ginseng

Panax ginseng

viral diseases

monkeypox virus

© 2023 The Korean Society of Ginseng. Publishing services by Elsevier B.V.

留言 (0)

沒有登入
gif